SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 607 filers reported holding SEAGEN INC in Q3 2023. The put-call ratio across all filers is 3.99 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,927,683 | +14.0% | 27,941 | +3.5% | 0.08% | +14.7% |
| Q2 2023 | $5,197,575 | -5.0% | 27,006 | -0.1% | 0.07% | -18.1% |
| Q1 2023 | $5,473,979 | +60.2% | 27,036 | +1.7% | 0.08% | +45.6% |
| Q4 2022 | $3,416,824 | -2.3% | 26,588 | +4.0% | 0.06% | -10.9% |
| Q3 2022 | $3,499,000 | -20.1% | 25,569 | +3.3% | 0.06% | -16.9% |
| Q2 2022 | $4,380,000 | +41.3% | 24,755 | +15.1% | 0.08% | +60.4% |
| Q1 2022 | $3,099,000 | +11.0% | 21,515 | +19.1% | 0.05% | -5.9% |
| Q4 2021 | $2,793,000 | -8.5% | 18,065 | +0.5% | 0.05% | -19.0% |
| Q3 2021 | $3,051,000 | +7.5% | 17,969 | 0.0% | 0.06% | +8.6% |
| Q2 2021 | $2,837,000 | +39.7% | 17,969 | +22.9% | 0.06% | +7.4% |
| Q1 2021 | $2,031,000 | -0.0% | 14,624 | +26.0% | 0.05% | -16.9% |
| Q4 2020 | $2,032,000 | – | 11,602 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |